Adam S. Sperling
- Hematology top 1%
- Multiple Myeloma Research and Treatments 36
- Acute Myeloid Leukemia Research 12
- Oncology top 5%
- CAR-T cell therapy research 14
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 4
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 19
- Genomics and Chromatin Dynamics 8
- Ubiquitin and proteasome pathways 6
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 7
- Co-authors
- Benjamin L. EbertChristopher J. GibsonNikhil C. MunshiMax JanMichael GrunsteinYu‐Tzu TaiMehmet SamurMariateresa Fulciniti
- Cited by
- HematologyOncologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Nature Communications (2 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Adam S. Sperling
71 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 724
- Oncology 698
- Genetics 214
- Molecular Biology 1.3k
- Cancer Research 191
Countries citing papers authored by Adam S. Sperling
This map shows the geographic impact of Adam S. Sperling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam S. Sperling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam S. Sperling more than expected).
Fields of papers citing papers by Adam S. Sperling
This network shows the impact of papers produced by Adam S. Sperling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam S. Sperling. The network helps show where Adam S. Sperling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam S. Sperling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 17 | |
| 10 | 2023 | 24 | |
| 11 | 2023 | 28 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 34 | |
| 14 | 2021 | 180 | |
| 15 | 2020 | 3 | |
| 16 | 2018 | 114 | |
| 17 | 2011 | 20 | |
| 18 | 2009 | 160 | |
| 19 | 2008 | 29 | |
| 20 | 2002 | 135 |
About Adam S. Sperling
Adam S. Sperling is a scholar working on Hematology, Oncology and Genetics, having authored 73 papers that have together received 2.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (36 papers), Protein Degradation and Inhibitors (19 papers), CAR-T cell therapy research (14 papers), Acute Myeloid Leukemia Research (12 papers), Genomics and Chromatin Dynamics (8 papers), Cancer Genomics and Diagnostics (7 papers), Ubiquitin and proteasome pathways (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (724 citations), Oncology (698 citations) and Genetics (214 citations). Adam S. Sperling has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Benjamin L. Ebert, Christopher J. Gibson, Nikhil C. Munshi, Max Jan, Michael Grunstein, Yu‐Tzu Tai, Mehmet Samur, Mariateresa Fulciniti, Kenneth C. Anderson and Jennifer A. Armstrong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.